https://creativecommons.org/licenses/by/4.0/ This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/ .
Armitage P. Gehan E. A. Statistical methods for the identification and use of prognostic factors. 13 1 15 1 1974 16 36 Int J Cancer 4594339 10.1002/ijc.2910130104
Heyn R. M. Joo P. Karon M. Nesbit M. Shore N. Breslow N. Weiner J. Reed A. Hammond D. BCG in the treatment of acute lymphocytic leukemia. 46 3 9 1975 431 442 Blood 1056801
Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. 50 3 3 1966 163 170 Cancer Chemother Rep 5910392
Mathé G. Amiel J. L. Schwarzenberg L. Schneider M. Cattan A. Schlumberger J. R. Hayat M. De Vassal F. Active immunotherapy for acute lymphoblastic leukaemia. 1 7597 5 4 1969 697 699 Lancet 4182654 10.1016/s0140-6736(69)92648-8
Peto R. Pike M. C. Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. 29 3 9 1973 579 584 Biometrics 4793138